| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| UroGen Pharma Ltd. | Chief Medical Officer | Ordinary Shares | 139,025 | $3,475,625 | $25 | 19 Nov 2025 | Direct |
| UroGen Pharma Ltd. | Chief Medical Officer | Restricted Stock Units | 1,667 | 07 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | 19 Nov 2025 | 1 | -$250,000 | 4 | Chief Medical Officer | 20 Nov 2025, 13:42 |
| URGN | UroGen Pharma Ltd. | 07 Sep 2025 | 3 | -$16,644 | 4 | Chief Medical Officer | 09 Sep 2025, 18:37 |
| URGN | UroGen Pharma Ltd. | 11 Aug 2025 | 1 | -$176,900 | 4 | Chief Medical Officer | 13 Aug 2025, 09:58 |
| URGN | UroGen Pharma Ltd. | 28 Jul 2025 | 2 | -$98,551 | 4 | Chief Medical Officer | 30 Jul 2025, 16:02 |
| URGN | UroGen Pharma Ltd. | 08 Jun 2025 | 3 | -$38,043 | 4 | Chief Medical Officer | 11 Jun 2025, 09:14 |
| URGN | UroGen Pharma Ltd. | 31 Jan 2025 | 10 | -$50,698 | 4 | Chief Medical Officer | 04 Feb 2025, 11:53 |
| URGN | UroGen Pharma Ltd. | 09 Sep 2024 | 3 | -$11,235 | 4 | Chief Medical Officer | 12 Sep 2024, 13:54 |
| URGN | UroGen Pharma Ltd. | 10 Jun 2024 | 3 | -$67,401 | 4 | Chief Medical Officer | 11 Jun 2024, 13:15 |
| URGN | UroGen Pharma Ltd. | 18 Mar 2024 | 1 | -$168,600 | 4 | Chief Medical Officer | 20 Mar 2024, 16:38 |
| URGN | UroGen Pharma Ltd. | 31 Jan 2024 | 3 | -$59,790 | 4/A | Chief Medical Officer | 05 Feb 2024, 21:15 |
| URGN | UroGen Pharma Ltd. | 31 Jan 2024 | 10 | -$59,638 | 4 | Chief Medical Officer | 02 Feb 2024, 19:07 |
| URGN | UroGen Pharma Ltd. | 07 Sep 2023 | 1 | $0 | 4 | Chief Medical Officer | 08 Sep 2023, 15:40 |
| URGN | UroGen Pharma Ltd. | 08 Jun 2023 | 1 | $0 | 4 | Chief Medical Officer | 09 Jun 2023, 15:26 |
| URGN | UroGen Pharma Ltd. | 31 Jan 2023 | 11 | -$19,228 | 4 | Chief Medical Officer | 02 Feb 2023, 12:02 |
| URGN | UroGen Pharma Ltd. | 20 Jan 2023 | 2 | $613,385 | 4 | Chief Medical Officer | 23 Jan 2023, 18:10 |
| URGN | UroGen Pharma Ltd. | 31 Oct 2022 | 3 | -$3,057 | 4 | Chief Medical Officer | 02 Nov 2022, 16:31 |
| URGN | UroGen Pharma Ltd. | 31 Jul 2022 | 3 | -$2,022 | 4 | Chief Medical Officer | 25 Aug 2022, 15:25 |
| URGN | UroGen Pharma Ltd. | 30 Apr 2022 | 3 | -$1,681 | 4 | Chief Medical Officer | 03 May 2022, 17:19 |
| URGN | UroGen Pharma Ltd. | 31 Jan 2022 | 8 | -$10,414 | 4 | Chief Medical Officer | 02 Feb 2022, 15:33 |
| URGN | UroGen Pharma Ltd. | 26 Jan 2022 | 3 | -$897 | 4 | Chief Medical Officer | 28 Jan 2022, 15:29 |
| URGN | UroGen Pharma Ltd. | 18 Nov 2021 | 1 | $2,096 | 4 | Chief Medical Officer | 19 Nov 2021, 14:05 |
| URGN | UroGen Pharma Ltd. | 31 Oct 2021 | 3 | -$4,427 | 4 | Chief Medical Officer | 02 Nov 2021, 15:45 |
| URGN | UroGen Pharma Ltd. | 26 Oct 2021 | 3 | -$1,746 | 4 | Chief Medical Officer | 28 Oct 2021, 14:04 |
| URGN | UroGen Pharma Ltd. | 31 Jul 2021 | 3 | -$3,800 | 4 | Chief Medical Officer | 03 Aug 2021, 19:07 |
| URGN | UroGen Pharma Ltd. | 26 Jul 2021 | 3 | -$1,575 | 4 | Chief Medical Officer | 28 Jul 2021, 09:11 |